Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
The accumulation and aggregation of α-synuclein (α-syn) is the main pathologic event in Parkinson’s disease (PD), dementia with Lewy bodies, and multiple system atrophy. α-Syn-seeded fibril formation and its induced toxicity occupy a major role in PD pathogenesis. Thus, assessing compounds that inhibit this seeding process is considered a key towards the therapeutics of synucleinopathies. Using biophysical and biochemical techniques and seeding-dependent cell viability assays, we screened a total of nine natural compounds of alkaloid origin extracted from Chinese medicinal herbs. Of these compounds, synephrine, trigonelline, cytisine, harmine, koumine, peimisine, and hupehenine exhibited in vitro inhibition of α-syn-seeded fibril formation. Furthermore, using cell viability assays, six of these compounds inhibited α-syn-seeding-dependent toxicity. These six potent inhibitors of amyloid fibril formation and toxicity caused by the seeding process represent a promising therapeutic strategy for the treatment of PD and other synucleinopathies.
Top-30
Journals
|
1
2
3
|
|
|
ACS Chemical Neuroscience
3 publications, 10.71%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.57%
|
|
|
Frontiers in Neurology
1 publication, 3.57%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 3.57%
|
|
|
Journal of Neurology
1 publication, 3.57%
|
|
|
Metabolic Brain Disease
1 publication, 3.57%
|
|
|
European Journal of Medicinal Chemistry Reports
1 publication, 3.57%
|
|
|
International Journal of Biological Macromolecules
1 publication, 3.57%
|
|
|
Molecules
1 publication, 3.57%
|
|
|
Annals of Neurology
1 publication, 3.57%
|
|
|
Mendeleev Communications
1 publication, 3.57%
|
|
|
Phytotherapy Research
1 publication, 3.57%
|
|
|
ChemBioChem
1 publication, 3.57%
|
|
|
Aquaculture Reports
1 publication, 3.57%
|
|
|
Medicinal Chemistry
1 publication, 3.57%
|
|
|
Cellulose
1 publication, 3.57%
|
|
|
Frontiers in Pharmacology
1 publication, 3.57%
|
|
|
Journal of Basic Microbiology
1 publication, 3.57%
|
|
|
NeuroToxicology
1 publication, 3.57%
|
|
|
Journal of Future Foods
1 publication, 3.57%
|
|
|
Mini-Reviews in Medicinal Chemistry
1 publication, 3.57%
|
|
|
Chemistry and Biodiversity
1 publication, 3.57%
|
|
|
Turkish Journal of Biochemistry
1 publication, 3.57%
|
|
|
Brain Research Bulletin
1 publication, 3.57%
|
|
|
Alzheimer's Research and Therapy
1 publication, 3.57%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 21.43%
|
|
|
Wiley
5 publications, 17.86%
|
|
|
Springer Nature
4 publications, 14.29%
|
|
|
Frontiers Media S.A.
3 publications, 10.71%
|
|
|
American Chemical Society (ACS)
3 publications, 10.71%
|
|
|
MDPI
2 publications, 7.14%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 7.14%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 3.57%
|
|
|
Walter de Gruyter
1 publication, 3.57%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.